EMEA-002233-PIP01-17-M01
Key facts
| Active substance |
Dasiglucagon
|
| Therapeutic area |
Endocrinology-Gynaecology-Fertility-Metabolism
|
| Decision number |
P/0393/2021
|
| PIP number |
EMEA-002233-PIP01-17-M01
|
| Pharmaceutical form(s) |
Solution for injection
|
| Condition(s) / indication(s) |
Treatment of hypoglycaemia
|
| Route(s) of administration |
Subcutaneous use
|
| Contact for public enquiries |
Zealand Pharma A/S
E-mail: info@zealandpharma.com |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|